{"ticker": "HSGX", "overview": {"cik": "1372299", "ticker": "OCGN", "name": "Ocugen, Inc.", "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "sic": "2836", "announcements": [{"form": "8-K", "date": "2026-10-15", "title": "FORM 8-K", "accession": "0001104659-26-115970", "price_sensitive": true}, {"form": "8-K", "date": "2026-10-15", "title": "FORM 8-K", "accession": "0001104659-26-115921", "price_sensitive": true}, {"form": "4", "date": "2026-10-13", "title": "FORM 4", "accession": "0001628280-26-065797", "price_sensitive": false}, {"form": "144", "date": "2026-10-09", "title": "Notice of proposed sale", "accession": "0001628280-26-065563", "price_sensitive": false}, {"form": "8-K", "date": "2026-10-06", "title": "Material event", "accession": "0001628280-26-065077", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-23", "title": "Material event", "accession": "0001628280-26-063084", "price_sensitive": true}, {"form": "4", "date": "2026-09-11", "title": "FORM 4", "accession": "0001628280-26-061626", "price_sensitive": false}, {"form": "144", "date": "2026-09-09", "title": "Notice of proposed sale", "accession": "0001628280-26-061150", "price_sensitive": false}, {"form": "8-K", "date": "2026-09-08", "title": "FORM 8-K", "accession": "0001104659-26-105968", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-08-14", "title": "Form DEFA14A", "accession": "0001104659-26-096110", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-13", "title": "Form SCHEDULE 13G/A", "accession": "0001274173-26-000196", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-07", "title": "Form SCHEDULE 13G", "accession": "0000093751-26-000513", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-06", "title": "Quarterly report", "accession": "0001628280-26-054057", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-06", "title": "FORM 8-K", "accession": "0001104659-26-091691", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-30", "title": "DEFA 14A", "accession": "0001140361-26-030261", "price_sensitive": false}, {"form": "DEF 14A", "date": "2026-07-30", "title": "Proxy statement", "accession": "0001140361-26-030258", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-07-29", "title": "Form SCHEDULE 13G", "accession": "0002012383-26-002838", "price_sensitive": false}, {"form": "PRE 14A", "date": "2026-07-20", "title": "Form PRE 14A", "accession": "0001140361-26-028979", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-13", "title": "FORM 8-K", "accession": "0001104659-26-082897", "price_sensitive": true}, {"form": "4", "date": "2026-06-17", "title": "FORM 4", "accession": "0001628280-26-043886", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-074078", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-074076", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-074073", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-074072", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-074064", "price_sensitive": false}]}, "description": "HSGX trades as HSGX. Privy Trades holds 80 insider filings for the company, from December 2014 to January 2019. Across those, 9 insiders disclosed 16 open-market purchases totalling $18.65M against 1 sale totalling $158.77K. The most recent filing on record is dated 8 February 2019.", "exchange": null, "stats": {"buy_n": 16, "buy_sum": 18654008.25, "sell_n": 1, "sell_sum": 158771.66999999998, "net": 18495236.58, "insiders": 9, "first_date": "2014-12-08", "last_date": "2019-01-15"}, "metrics": {"ticker": "HSGX", "has_prices": false}, "trades": [{"id": "0000899243-19-003145", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Kevin Rakin", "who_key": "RAKIN KEVIN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924319003145/0000899243-19-003145-index.htm", "trade_date": "2019-02-08", "timestamp": "2019-02-08", "mins": 4067509}, {"id": "0000899243-19-003146", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Michael Lewis", "who_key": "Lewis Michael", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924319003146/0000899243-19-003146-index.htm", "trade_date": "2019-02-08", "timestamp": "2019-02-08", "mins": 4067509}, {"id": "0000899243-19-003147", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Wilmslow Estates Ltd", "who_key": "Wilmslow Estates Ltd", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "10% owner files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924319003147/0000899243-19-003147-index.htm", "trade_date": "2019-02-08", "timestamp": "2019-02-08", "mins": 4067509}, {"id": "0001567619-19-001160", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Randal J. Kirk", "who_key": "KIRK RANDAL J", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "SELL", "amount": 158771.66999999998, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Big holder trims $159K of HSGX", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000156761919001160/0001567619-19-001160-index.htm", "trade_date": "2019-01-15", "timestamp": "2019-01-15", "mins": 4102069}, {"id": "0000899243-18-026559", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Michael Lewis", "who_key": "Lewis Michael", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 0.0, "score": 17.6, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "3 insiders pile into HSGX", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026559/0000899243-18-026559-index.htm", "trade_date": "2018-10-10", "timestamp": "2018-10-10", "mins": 4241749}, {"id": "0000899243-18-026560", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Wilmslow Estates Ltd", "who_key": "Wilmslow Estates Ltd", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 0.0, "score": 15.1, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Major holder piles $0 into HSGX", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026560/0000899243-18-026560-index.htm", "trade_date": "2018-10-10", "timestamp": "2018-10-10", "mins": 4241749}, {"id": "0000899243-18-026561", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Kevin Rakin", "who_key": "RAKIN KEVIN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 0.0, "score": 30.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "HSGX lands a director's $0", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026561/0000899243-18-026561-index.htm", "trade_date": "2018-10-10", "timestamp": "2018-10-10", "mins": 4241749}, {"id": "0000899243-18-026056", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Adam Gridley", "who_key": "Gridley Adam", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026056/0000899243-18-026056-index.htm", "trade_date": "2018-10-01", "timestamp": "2018-10-01", "mins": 4254709}, {"id": "0000899243-18-026057", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Jonathan I. Lieber", "who_key": "Lieber Jonathan I", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CFO files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026057/0000899243-18-026057-index.htm", "trade_date": "2018-10-01", "timestamp": "2018-10-01", "mins": 4254709}, {"id": "0000899243-18-026058", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Donald Haut", "who_key": "Haut Donald", "role": "Chief Business Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026058/0000899243-18-026058-index.htm", "trade_date": "2018-10-01", "timestamp": "2018-10-01", "mins": 4254709}, {"id": "0000899243-18-026059", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Stephen Richard Kennedy", "who_key": "Kennedy Stephen Richard", "role": "Chief Operating Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026059/0000899243-18-026059-index.htm", "trade_date": "2018-10-01", "timestamp": "2018-10-01", "mins": 4254709}, {"id": "0000899243-18-026060", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Lynne E. Kelley", "who_key": "Kelley Lynne E", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026060/0000899243-18-026060-index.htm", "trade_date": "2018-10-01", "timestamp": "2018-10-01", "mins": 4254709}, {"id": "0000899243-18-020985", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Lynne E. Kelley", "who_key": "Kelley Lynne E", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318020985/0000899243-18-020985-index.htm", "trade_date": "2018-07-31", "timestamp": "2018-07-31", "mins": 4343989}, {"id": "0000899243-18-017186", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "John Johnson", "who_key": "JOHNSON JOHN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318017186/0000899243-18-017186-index.htm", "trade_date": "2018-06-15", "timestamp": "2018-06-15", "mins": 4410229}, {"id": "0000899243-18-017187", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Joshua J. Baltzell", "who_key": "Baltzell Joshua J", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318017187/0000899243-18-017187-index.htm", "trade_date": "2018-06-15", "timestamp": "2018-06-15", "mins": 4410229}, {"id": "0000899243-18-017188", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Garheng Kong", "who_key": "Kong Garheng", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318017188/0000899243-18-017188-index.htm", "trade_date": "2018-06-15", "timestamp": "2018-06-15", "mins": 4410229}, {"id": "0000899243-18-017189", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Kevin Rakin", "who_key": "RAKIN KEVIN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318017189/0000899243-18-017189-index.htm", "trade_date": "2018-06-15", "timestamp": "2018-06-15", "mins": 4410229}, {"id": "0000899243-18-017190", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Michael Lewis", "who_key": "Lewis Michael", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318017190/0000899243-18-017190-index.htm", "trade_date": "2018-06-15", "timestamp": "2018-06-15", "mins": 4410229}, {"id": "0000899243-18-017191", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "David N. Gill", "who_key": "GILL DAVID N", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318017191/0000899243-18-017191-index.htm", "trade_date": "2018-06-15", "timestamp": "2018-06-15", "mins": 4410229}, {"id": "0000899243-18-013445", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Adam Gridley", "who_key": "Gridley Adam", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 4300.0, "score": 39.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "4 insiders now buying HSGX", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318013445/0000899243-18-013445-index.htm", "trade_date": "2018-05-16", "timestamp": "2018-05-16", "mins": 4453429}, {"id": "0000899243-18-010326", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Susan B. Washer", "who_key": "Washer Susan B.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318010326/0000899243-18-010326-index.htm", "trade_date": "2018-04-16", "timestamp": "2018-04-16", "mins": 4496629}, {"id": "0000899243-18-004807", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Adam Gridley", "who_key": "Gridley Adam", "role": "See Remarks, Director", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318004807/0000899243-18-004807-index.htm", "trade_date": "2018-02-16", "timestamp": "2018-02-16", "mins": 4581589}, {"id": "0000899243-18-004809", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Donald Haut", "who_key": "Haut Donald", "role": "Chief Business Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318004809/0000899243-18-004809-index.htm", "trade_date": "2018-02-16", "timestamp": "2018-02-16", "mins": 4581589}, {"id": "0000899243-18-004812", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Jonathan I. Lieber", "who_key": "Lieber Jonathan I", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CFO files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318004812/0000899243-18-004812-index.htm", "trade_date": "2018-02-16", "timestamp": "2018-02-16", "mins": 4581589}, {"id": "0000899243-18-004813", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Stephen Richard Kennedy", "who_key": "Kennedy Stephen Richard", "role": "Chief Technology Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318004813/0000899243-18-004813-index.htm", "trade_date": "2018-02-16", "timestamp": "2018-02-16", "mins": 4581589}, {"id": "0000899243-17-024133", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Stephen Richard Kennedy", "who_key": "Kennedy Stephen Richard", "role": "EVP and COO", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924317024133/0000899243-17-024133-index.htm", "trade_date": "2017-10-10", "timestamp": "2017-10-10", "mins": 4767349}, {"id": "0000899243-17-020616", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "David N. Gill", "who_key": "GILL DAVID N", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 5439.0, "score": 28.8, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "That makes 5 insiders into HSGX", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924317020616/0000899243-17-020616-index.htm", "trade_date": "2017-08-16", "timestamp": "2017-08-16", "mins": 4846549}, {"id": "0000899243-17-016390", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Garheng Kong", "who_key": "Kong Garheng", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924317016390/0000899243-17-016390-index.htm", "trade_date": "2017-06-13", "timestamp": "2017-06-13", "mins": 4938709}, {"id": "0000899243-17-016391", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "David N. Gill", "who_key": "GILL DAVID N", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924317016391/0000899243-17-016391-index.htm", "trade_date": "2017-06-13", "timestamp": "2017-06-13", "mins": 4938709}, {"id": "0000899243-17-016392", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Joshua J. Baltzell", "who_key": "Baltzell Joshua J", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on HSGX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924317016392/0000899243-17-016392-index.htm", "trade_date": "2017-06-13", "timestamp": "2017-06-13", "mins": 4938709}], "recent_buys": [{"id": "0000899243-18-026561", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Kevin Rakin", "who_key": "RAKIN KEVIN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 0.0, "score": 30.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "HSGX lands a director's $0", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026561/0000899243-18-026561-index.htm", "trade_date": "2018-10-10", "timestamp": "2018-10-10", "mins": 4241749}, {"id": "0000899243-18-026560", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Wilmslow Estates Ltd", "who_key": "Wilmslow Estates Ltd", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 0.0, "score": 15.1, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Major holder piles $0 into HSGX", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026560/0000899243-18-026560-index.htm", "trade_date": "2018-10-10", "timestamp": "2018-10-10", "mins": 4241749}, {"id": "0000899243-18-026559", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Michael Lewis", "who_key": "Lewis Michael", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 0.0, "score": 17.6, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "3 insiders pile into HSGX", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026559/0000899243-18-026559-index.htm", "trade_date": "2018-10-10", "timestamp": "2018-10-10", "mins": 4241749}, {"id": "0000899243-18-013445", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Adam Gridley", "who_key": "Gridley Adam", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 4300.0, "score": 39.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "4 insiders now buying HSGX", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318013445/0000899243-18-013445-index.htm", "trade_date": "2018-05-16", "timestamp": "2018-05-16", "mins": 4453429}, {"id": "0000899243-17-020616", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "David N. Gill", "who_key": "GILL DAVID N", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 5439.0, "score": 28.8, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "That makes 5 insiders into HSGX", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924317020616/0000899243-17-020616-index.htm", "trade_date": "2017-08-16", "timestamp": "2017-08-16", "mins": 4846549}, {"id": "0000899243-17-013537", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "David N. Gill", "who_key": "GILL DAVID N", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 5040.0, "score": 30.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 6 buying HSGX", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924317013537/0000899243-17-013537-index.htm", "trade_date": "2017-05-16", "timestamp": "2017-05-16", "mins": 4979029}, {"id": "0000899243-16-035625", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "David N. Gill", "who_key": "GILL DAVID N", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 4950.0, "score": 33.3, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The whole bench is buying HSGX \u2014 6 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924316035625/0000899243-16-035625-index.htm", "trade_date": "2016-12-15", "timestamp": "2016-12-15", "mins": 5197909}, {"id": "0000899243-16-035615", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "David N. Gill", "who_key": "GILL DAVID N", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 9600.0, "score": 27.3, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "That makes 6 insiders into HSGX", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924316035615/0000899243-16-035615-index.htm", "trade_date": "2016-12-09", "timestamp": "2016-12-09", "mins": 5206549}, {"id": "0000899243-16-034849", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Jonathan I. Lieber", "who_key": "Lieber Jonathan I", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 9730.5, "score": 34.9, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "6 insiders now buying HSGX", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924316034849/0000899243-16-034849-index.htm", "trade_date": "2016-12-02", "timestamp": "2016-12-02", "mins": 5216629}, {"id": "0000899243-16-034848", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Adam Gridley", "who_key": "Gridley Adam", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 10039.499999999998, "score": 37.5, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "HSGX draws its 7th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924316034848/0000899243-16-034848-index.htm", "trade_date": "2016-12-01", "timestamp": "2016-12-01", "mins": 5218069}, {"id": "0001235802-16-000308", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Split ROCK Partners II, LP", "who_key": "SPLIT ROCK PARTNERS II, LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 622802.25, "score": 49.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "7 insiders now buying HSGX", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000123580216000308/0001235802-16-000308-index.htm", "trade_date": "2016-09-29", "timestamp": "2016-09-29", "mins": 5308789}, {"id": "0001144204-14-073112", "src": "INSIDERS", "ticker": "HSGX", "cik": "1372299", "company": "Ocugen, Inc.", "company_raw": "HISTOGENICS CORP", "who": "Sofinnova Venture Partners VIII, L.P.", "who_key": "Sofinnova Venture Partners VIII, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 5502178.0, "score": 62.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "8 insiders now buying HSGX", "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000114420414073112/0001144204-14-073112-index.htm", "trade_date": "2014-12-08", "timestamp": "2014-12-08", "mins": 6260629}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Sofinnova Venture Partners VIII, L.P.", "who_key": "Sofinnova Venture Partners VIII, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 5502178.0, "sold": 0, "net": 5502178.0, "trades": 1, "top_score": 62.1, "lean": "buying", "history": [{"action": "BUY", "amount": 5502178.0, "date": "2014-12-08", "score": 62.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000114420414073112/0001144204-14-073112-index.htm"}], "latest": {"action": "BUY", "amount": 5502178.0, "date": "2014-12-08", "score": 62.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000114420414073112/0001144204-14-073112-index.htm"}}, {"who": "Wilmslow Estates Ltd", "who_key": "Wilmslow Estates Ltd", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 4344098.0, "sold": 0, "net": 4344098.0, "trades": 2, "top_score": 60.0, "lean": "buying", "history": [{"action": "BUY", "amount": 0, "date": "2018-10-10", "score": 15.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026560/0000899243-18-026560-index.htm"}, {"action": "BUY", "amount": 4344098.0, "date": "2014-12-08", "score": 60.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000120919114073667/0001209191-14-073667-index.htm"}], "latest": {"action": "BUY", "amount": 0, "date": "2018-10-10", "score": 15.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026560/0000899243-18-026560-index.htm"}}, {"who": "Michael Lewis", "who_key": "Lewis Michael", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "bought": 4344098.0, "sold": 0, "net": 4344098.0, "trades": 2, "top_score": 62.5, "lean": "buying", "history": [{"action": "BUY", "amount": 0, "date": "2018-10-10", "score": 17.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026559/0000899243-18-026559-index.htm"}, {"action": "BUY", "amount": 4344098.0, "date": "2014-12-08", "score": 62.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000120919114073655/0001209191-14-073655-index.htm"}], "latest": {"action": "BUY", "amount": 0, "date": "2018-10-10", "score": 17.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026559/0000899243-18-026559-index.htm"}}, {"who": "Split ROCK Partners II, LP", "who_key": "SPLIT ROCK PARTNERS II, LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 4290928.25, "sold": 0, "net": 4290928.25, "trades": 2, "top_score": 60.0, "lean": "buying", "history": [{"action": "BUY", "amount": 622802.25, "date": "2016-09-29", "score": 49.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000123580216000308/0001235802-16-000308-index.htm"}, {"action": "BUY", "amount": 3668126.0, "date": "2014-12-08", "score": 60.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000123580214000161/0001235802-14-000161-index.htm"}], "latest": {"action": "BUY", "amount": 622802.25, "date": "2016-09-29", "score": 49.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000123580216000308/0001235802-16-000308-index.htm"}}, {"who": "Randal J. Kirk", "who_key": "KIRK RANDAL J", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 0, "sold": 158771.66999999998, "net": -158771.66999999998, "trades": 1, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 158771.66999999998, "date": "2019-01-15", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000156761919001160/0001567619-19-001160-index.htm"}], "latest": {"action": "SELL", "amount": 158771.66999999998, "date": "2019-01-15", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000156761919001160/0001567619-19-001160-index.htm"}}, {"who": "Kevin Rakin", "who_key": "RAKIN KEVIN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 123607.0, "sold": 0, "net": 123607.0, "trades": 2, "top_score": 43.6, "lean": "buying", "history": [{"action": "BUY", "amount": 0, "date": "2018-10-10", "score": 30.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026561/0000899243-18-026561-index.htm"}, {"action": "BUY", "amount": 123607.0, "date": "2014-12-08", "score": 43.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000120919114073666/0001209191-14-073666-index.htm"}], "latest": {"action": "BUY", "amount": 0, "date": "2018-10-10", "score": 30.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318026561/0000899243-18-026561-index.htm"}}, {"who": "David N. Gill", "who_key": "GILL DAVID N", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 25029.0, "sold": 0, "net": 25029.0, "trades": 4, "top_score": 33.3, "lean": "buying", "history": [{"action": "BUY", "amount": 5439.0, "date": "2017-08-16", "score": 28.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924317020616/0000899243-17-020616-index.htm"}, {"action": "BUY", "amount": 5040.0, "date": "2017-05-16", "score": 30.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924317013537/0000899243-17-013537-index.htm"}, {"action": "BUY", "amount": 4950.0, "date": "2016-12-15", "score": 33.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924316035625/0000899243-16-035625-index.htm"}, {"action": "BUY", "amount": 9600.0, "date": "2016-12-09", "score": 27.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924316035615/0000899243-16-035615-index.htm"}], "latest": {"action": "BUY", "amount": 5439.0, "date": "2017-08-16", "score": 28.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924317020616/0000899243-17-020616-index.htm"}}, {"who": "Adam Gridley", "who_key": "Gridley Adam", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "bought": 14339.499999999998, "sold": 0, "net": 14339.499999999998, "trades": 2, "top_score": 39.7, "lean": "buying", "history": [{"action": "BUY", "amount": 4300.0, "date": "2018-05-16", "score": 39.7, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318013445/0000899243-18-013445-index.htm"}, {"action": "BUY", "amount": 10039.499999999998, "date": "2016-12-01", "score": 37.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924316034848/0000899243-16-034848-index.htm"}], "latest": {"action": "BUY", "amount": 4300.0, "date": "2018-05-16", "score": 39.7, "source_url": "https://www.sec.gov/Archives/edgar/data/1372299/000089924318013445/0000899243-18-013445-index.htm"}}], "activity": [], "announcements": [{"form": "8-K", "date": "2026-10-15", "title": "FORM 8-K", "accession": "0001104659-26-115970", "price_sensitive": true}, {"form": "8-K", "date": "2026-10-15", "title": "FORM 8-K", "accession": "0001104659-26-115921", "price_sensitive": true}, {"form": "4", "date": "2026-10-13", "title": "FORM 4", "accession": "0001628280-26-065797", "price_sensitive": false}, {"form": "144", "date": "2026-10-09", "title": "Notice of proposed sale", "accession": "0001628280-26-065563", "price_sensitive": false}, {"form": "8-K", "date": "2026-10-06", "title": "Material event", "accession": "0001628280-26-065077", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-23", "title": "Material event", "accession": "0001628280-26-063084", "price_sensitive": true}, {"form": "4", "date": "2026-09-11", "title": "FORM 4", "accession": "0001628280-26-061626", "price_sensitive": false}, {"form": "144", "date": "2026-09-09", "title": "Notice of proposed sale", "accession": "0001628280-26-061150", "price_sensitive": false}, {"form": "8-K", "date": "2026-09-08", "title": "FORM 8-K", "accession": "0001104659-26-105968", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-08-14", "title": "Form DEFA14A", "accession": "0001104659-26-096110", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-13", "title": "Form SCHEDULE 13G/A", "accession": "0001274173-26-000196", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-07", "title": "Form SCHEDULE 13G", "accession": "0000093751-26-000513", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-06", "title": "Quarterly report", "accession": "0001628280-26-054057", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-06", "title": "FORM 8-K", "accession": "0001104659-26-091691", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-30", "title": "DEFA 14A", "accession": "0001140361-26-030261", "price_sensitive": false}, {"form": "DEF 14A", "date": "2026-07-30", "title": "Proxy statement", "accession": "0001140361-26-030258", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-07-29", "title": "Form SCHEDULE 13G", "accession": "0002012383-26-002838", "price_sensitive": false}, {"form": "PRE 14A", "date": "2026-07-20", "title": "Form PRE 14A", "accession": "0001140361-26-028979", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-13", "title": "FORM 8-K", "accession": "0001104659-26-082897", "price_sensitive": true}, {"form": "4", "date": "2026-06-17", "title": "FORM 4", "accession": "0001628280-26-043886", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-074078", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-074076", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-074073", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-074072", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-074064", "price_sensitive": false}], "performance": {"ticker": "HSGX", "has_prices": false, "summary": null, "buys": [{"who": "RAKIN KEVIN", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 0.0, "date": "2018-10-10", "score": 30.0, "ref_price": null, "return": null}, {"who": "Wilmslow Estates Ltd", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 0.0, "date": "2018-10-10", "score": 15.1, "ref_price": null, "return": null}, {"who": "Lewis Michael", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 0.0, "date": "2018-10-10", "score": 17.6, "ref_price": null, "return": null}, {"who": "Gridley Adam", "person_type": "CEO", "person_label": "CEOs", "role": "President and CEO, Director", "amount": 4300.0, "date": "2018-05-16", "score": 39.7, "ref_price": null, "return": null}, {"who": "GILL DAVID N", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 5439.0, "date": "2017-08-16", "score": 28.8, "ref_price": null, "return": null}, {"who": "GILL DAVID N", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 5040.0, "date": "2017-05-16", "score": 30.0, "ref_price": null, "return": null}, {"who": "GILL DAVID N", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 4950.0, "date": "2016-12-15", "score": 33.3, "ref_price": null, "return": null}, {"who": "GILL DAVID N", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 9600.0, "date": "2016-12-09", "score": 27.3, "ref_price": null, "return": null}, {"who": "Lieber Jonathan I", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Financial Officer", "amount": 9730.5, "date": "2016-12-02", "score": 34.9, "ref_price": null, "return": null}, {"who": "Gridley Adam", "person_type": "CEO", "person_label": "CEOs", "role": "President and CEO, Director", "amount": 10039.499999999998, "date": "2016-12-01", "score": 37.5, "ref_price": null, "return": null}, {"who": "SPLIT ROCK PARTNERS II, LP", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 622802.25, "date": "2016-09-29", "score": 49.0, "ref_price": null, "return": null}, {"who": "Sofinnova Venture Partners VIII, L.P.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 5502178.0, "date": "2014-12-08", "score": 62.1, "ref_price": null, "return": null}, {"who": "Wilmslow Estates Ltd", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 4344098.0, "date": "2014-12-08", "score": 60.0, "ref_price": null, "return": null}, {"who": "RAKIN KEVIN", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 123607.0, "date": "2014-12-08", "score": 43.6, "ref_price": null, "return": null}, {"who": "Lewis Michael", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 4344098.0, "date": "2014-12-08", "score": 62.5, "ref_price": null, "return": null}, {"who": "SPLIT ROCK PARTNERS II, LP", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 3668126.0, "date": "2014-12-08", "score": 60.0, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}